Britain's leading pharma company AstraZeneca, which has provided the vaccine worldwide during the Covid pandemic, has started recalling it from the market. Many complaints of blood clotting and low platelet count have been registered against its vaccine 'Vaxjaveria'. However, the company has claimed in the statement that a new version of the vaccine is available, hence the old stock has started being ordered.
Serum Institute of India, in collaboration with AstraZeneca, had made 'Covishield' vaccine available in India. AstraZeneca developed the Covid-19 vaccine in collaboration with Oxford University. It was made available as Vaxjavria in Europe and Covishield in India.
The European Union (EU) drug regulator the European Medicines Agency issued a notice on Tuesday confirming that Vaxzevria is no longer authorized for use in the 27-member economic bloc.
The company had decided to recall the vaccine in March itself. It said the marketing authority is working with regulatory authorities around the world to seek the recall of Vaxzeveria.
The company has accepted side effects in rare cases: According to global media reports, earlier AstraZeneca had admitted that its COVID-19 vaccine could cause side effects in rare cases. Which is called thrombosis with thrombocytopenia syndrome (TTS). More than 2.20 billion doses of COVID-19 vaccines have been administered in India and the majority of them were Covishield. Some people have also complained about the side effects of Covishield.
More than three billion doses are supplied globally
The company said that according to independent estimates, more than 65 lakh lives were saved in the first year of use alone, and more than three billion doses were supplied globally. That said, our efforts have been recognized by governments around the world and are widely recognized as a critical component of ending the global pandemic. Many cases are going on in the British court regarding the side effects of AstraZeneca.
Stop supply in December 2021 itself
Pune-based Serum Institute of India (SII) on Wednesday said it had stopped manufacturing and supplying additional doses of Covishield in December 2021. AstraZeneca has voluntarily withdrawn "marketing". Its Covid vaccine, sold as Covishield in India and Vaxjavria in Europe, has been approved.
Ajmer Train Conspiracy After Kanpur in UP, now a case of conspiracy to overturn a train has come
On the night of the incident, when the Kolkata rape victim had a panic attack and pleaded to be t
ADGP Suicide: Postmortem of Puran Kumar's body begins, wife arrives at PGI with Chandigarh SSP
The post-mortem examination of the body of Haryana ADGP Y. Puran Kumar has begun. Chandigarh SSP
This horror show has taken Netflix by storm, with all seasons trending in the top 10.
There are many shows on Netflix whose new seasons viewers eagerly await. New seasons often trend
Congress MP and Leader of Opposition in Lok Sabha Rahul Gandhi has once again raised questions ab
Delhi's new CM Atishi took charge as Chief Minister on Monday. During this, she said that the cha
There was a stir in the Tamil film industry when the news of the tragic death of well-known stunt
Ashnoor Kaur, a former contestant of 'Bigg Boss 19', made many friends during her time on the sho
India will take on Pakistan in the Champions Trophy 2025 on Sunday, February 23 at the Dubai Inte
'Attack on democracy,' director Vivek Agnihotri's wife lashes out over The Bengal Files controversy
Director Vivek Agnihotri, who created a stir at the box office with the film The Kashmir Files, i
